• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Valemetostat

CAS No. 1809336-39-7

Valemetostat ( —— )

产品货号. M21864 CAS No. 1809336-39-7

Valemetostat 是 zeste 同源物 1 (EZH1) 和 EZH2.1 增强子的双重抑制剂,它在无细胞测定中抑制含有 EZH1 或 EZH2 作为催化亚基的多梳抑制复合物 2 (PRC2)(IC50 分别 = 8.4 和 2.5 nM) 。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥1596 有现货
10MG ¥2811 有现货
25MG ¥4682 有现货
50MG ¥6683 有现货
100MG ¥8829 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Valemetostat
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Valemetostat 是 zeste 同源物 1 (EZH1) 和 EZH2.1 增强子的双重抑制剂,它在无细胞测定中抑制含有 EZH1 或 EZH2 作为催化亚基的多梳抑制复合物 2 (PRC2)(IC50 分别 = 8.4 和 2.5 nM) 。
  • 产品描述
    Valemetostat is a dual inhibitor of enhancer of zeste homolog 1 (EZH1) and EZH2.1 It inhibits polycomb repressive complex 2 (PRC2) containing EZH1 or EZH2 as the catalytic subunit in cell-free assays (IC50s = 8.4 and 2.5 nM, respectively). Valemetostat inhibits trimethylation of histone H3 lysine 27 in HCT116 cells (IC50 = 0.44 nM). It inhibits the growth of Karpas-422 diffuse large B cell lymphoma (DLBCL) cells (GI50 = 4.8 nM).(In Vitro):Valemetostat (1-1000 nM) strongly and specifically inhibits EZH1 and EZH2 with IC50 values <10 nM.Valemetostat (100 nM; 7 d) effectively removes H3K27me3 and also prevents unexpected gain of H3K27me3.Valemetostat (0.1-100 nM; 7 d) potently inhibits H3K27me3 by low-dose treatment in the sensitive lymphoma types.(In Vivo):Valemetostat (0.01 mg/g; i.p.; once) prevents the changes of H3K27me3 after exercise training.
  • 体外实验
    Valemetostat (1-1000 nM) strongly and specifically inhibits EZH1 and EZH2 with IC50 values <10 nM.Valemetostat (100 nM; 7 d) effectively removes H3K27me3 and also prevents unexpected gain of H3K27me3. Valemetostat (0.1-100 nM; 7 d) potently inhibits H3K27me3 by low-dose treatmentin the sensitive lymphoma types.
  • 体内实验
    Valemetostat (0.01 mg/g; i.p.; once) prevents the changes of H3K27me3 after exercise training. Animal Model:Male C57BL/6J mice with chronic and acute running exercise or without exercise Dosage:0.01 mg/g Administration:Intraperitoneal injection; 0.01 mg/g; 30 min before the start of running exercise Result:Significantly increased the level of H3K27me3 , slightly decresed EZH1 level , upregulated the EZH2 level and increased the level of phosphorylated AMPK after exercise. Repressed myonuclear H3K27me3 accumulation during training and caused a failure of adaptive changes.
  • 同义词
    ——
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    EZH1/2
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    1809336-39-7
  • 分子量
    488.02
  • 分子式
    C26H34ClN3O4
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO : 70 mg/mL (143.44 mM)
  • SMILES
    CC1=CC(=C(C(=O)N1)CNC(=O)C2=CC(=C3C(=C2C)OC(O3)(C)C4CCC(CC4)N(C)C)Cl)C
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

产品手册
关联产品
  • Senecivernine N-oxid...

    The herbs of Senecio inaequidens D.C

  • Inaxaplin

    Inaxaplin 是一种载脂蛋白 L1 (APOL1) 功能抑制剂(WO2020131807,化合物 2)。 Inaxaplin 可用于肾脏疾病的研究。

  • Nardosinone

    Nardosinone 对 Ang II 诱导的 H9c2 细胞肥大有抑制作用,可能是通过靶向 PI3K/Akt 和 MEK/ERK 信号通路介导的。